Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Multiple Endocrine Neoplasia Type 1 4Neoplasms 2Skin Neoplasms 1Rosacea 1Psoriasis 1Pregnancy Complications 1Neurologic Manifestations 1Metabolic Diseases 1Melanoma 1Endocrine System Diseases 1Diabetes Mellitus 1Dermatitis, Atopic 1Cerebrovascular Disorders 1Cardiovascular Diseases 1

Interventions

Gemcitabine 3Albumin-Bound Paclitaxel 3130-nm albumin-bound paclitaxel 3Ocoxin 2Metformin 2Clomiphene 2relacorilant 1pralsetinib 1pembrolizumab 1parathyroid hormone-related peptide (1-36) 1niraparib 1napabucasin 1Spironolactone 1Paclitaxel 1Octreotide 1Leuprolide 1Irinotecan 1Immune Checkpoint Inhibitors 1Filgrastim 1Eating 1Cisplatin 1Chorionic Gonadotropin 1Carboplatin 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Endocrine System Diseases × Eating × Clear all
NCT03328546 2023-04-14

Dietary Patterns and Health Outcomes (Cardiovascular, Metabolic, Endocrine, Neurological, Skeletal Muscular, Cancer)

Harvard School of Public Health (HSPH)

Completed
116,671 enrolled

Cardiovascular Diseases, Cerebrovascular Disorders, Diabetes Mellitus, Endocrine System Diseases, Metabolic Diseases, Neoplasms, Neurologic Manifestations, Pregnancy Complications

Data powered by HemOnc (CC BY 4.0) Colophon âš¡